U.S. stocks fall as Waller news weighs; Apple adds to gains
LONDON - BioPharma Credit PLC (LSE:BPCR), a specialist life sciences debt investor, has declared an interim dividend of 1.75 cents per share for the quarterly period ending June 30, 2025, according to a press release statement.
The dividend will be payable on July 31, 2025, to shareholders on the register as of June 27, 2025. The ex-dividend date is set for June 26, 2025.
The company has designated the entire amount of this interim dividend as an interest distribution, which means shareholders receiving the dividend will be treated as though they have received a payment of interest for UK tax purposes. This designation will reduce the corporation tax payable by the company.
BioPharma Credit is currently targeting a 7-cent base annual dividend per ordinary share. The company paid dividends of 10.18 cents in 2024, 10.21 cents in 2023, and 13.08 cents in 2022.
The default payment currency for dividends is US dollars, though shareholders can elect to receive payment in sterling (GBP). The deadline for currency election is June 27, 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.